Susquehanna Portfolio Strategies
LEGN icon

Susquehanna Portfolio Strategies’s Legend Biotech LEGN Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Buy
+55,533
New +$1.5M 0.03% 475
2025
Q3 		– Sell
-24,491
Closed -$869K – 1082
2025
Q2 		$869K Buy
+24,491
New +$794K 0.02% 537

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Susquehanna Portfolio Strategies's LEGN Position: Q2 2026 in Review

Susquehanna Portfolio Strategies opened a new position in Legend Biotech (LEGN) in Q2 2026: 55,533 shares worth $1.6M. The stake represents 0.03% of the portfolio and ranks #475 among its holdings. This is a return to the name: Susquehanna Portfolio Strategies previously reported a position in LEGN as recently as Q2 2025.

Susquehanna Portfolio Strategies first reported a position in LEGN in Q2 2025 and has held it in 2 quarters since. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Susquehanna Portfolio Strategies held 55,533 shares of Legend Biotech worth $1.6M as of Q2 2026.
  • Legend Biotech was a new Susquehanna Portfolio Strategies position in Q2 2026.
  • Legend Biotech made up 0.03% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #475 holding.
  • Susquehanna Portfolio Strategies first reported a position in Legend Biotech in Q2 2025 and has held it in 2 quarters since.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.